GATA1 is overexpressed in patients with essential thrombocythemia and it is normalized by anagrelide treatment

被引：0
|
作者：
Brown, L. [1 ]
Graham, C. [1 ]
Rinaldi, C. R. [1 ,2 ]
机构：
[1] Lincoln Univ, Sch Life Sci, MPN LAB, Lincoln, England
[2] United Lincolnshire Hosp NHS Trust, Dept Haematol, Lincoln, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2014年 / 165卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
171
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [21] Anagrelide for the treatment of essential thrombocythemia: a survey among European hematologists/oncologists
    Reilly, John T.
    HEMATOLOGY, 2009, 14 (01) : 1 - 10
  • [22] Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment
    Hultdin, Magnus
    Sundstrom, Gunnel
    Wahlin, Anders
    Lundstrom, Berith
    Birgegard, Gunnar
    Engstrom-Laurent, Anna
    MEDICAL ONCOLOGY, 2007, 24 (01) : 63 - 70
  • [23] Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment
    Magnus Hultdin
    Gunnel Sundström
    Anders Wahlin
    Berith Lundström
    Jan Samuelsson
    Gunnar Birgegård
    Anna Engström-Laurent
    Medical Oncology, 2007, 24 : 63 - 70
  • [24] Long-term use of anagrelide in young patients with essential thrombocythemia
    Storen, EC
    Tefferi, A
    BLOOD, 2001, 97 (04) : 863 - 866
  • [25] GATA1 is over-expressed in essential thrombocytemia
    Rinaldi, Ciro R.
    Li, Donglan
    Ciancia, Rosanna
    Picardi, Marco
    Rinaldi, Paola
    Martinelli, Vincenzo
    Nucifora, Giuseppina
    Pape, Fabrizio
    Rotoli, Bruno
    BLOOD, 2007, 110 (11) : 458A - 459A
  • [26] ADHERENCE SUPPORT PROGRAM FOR PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET) TREATED WITH ANAGRELIDE
    Ramirez, G.
    Cardenes, J.
    Rejas, R.
    Plaza, S.
    Garcia-Ort, L.
    Navas, V.
    HAEMATOLOGICA, 2014, 99 : 669 - 669
  • [27] THERAPY WITH ANAGRELIDE IN PATIENTS AFFECTED BY ESSENTIAL THROMBOCYTHEMIA - PRELIMINARY-RESULTS
    MAZZUCCONI, MG
    DESANCTIS, V
    CHISTOLINI, A
    DRAGONI, F
    MANDELLI, F
    HAEMATOLOGICA, 1992, 77 (04) : 315 - 317
  • [28] EFFECT OF ANAGRELIDE ON PLATELET, COAGULANT AND ENDOTHELIAL FUNCTION IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
    Cacciola, R. R.
    Di Francesco, E.
    Pezzella, F.
    Tibullo, D.
    Cacciola, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 584 - 584
  • [29] Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia
    Gugliotta, Luigi
    Tieghi, Alessia
    Tortorella, Giovanni
    Scalzulli, Potito Rosario
    Ciancia, Rosanna
    Lunghi, Monia
    Cacciola, Emma
    Cacciola, Rossella
    Candoni, Anna
    Crugnola, Monica
    Codeluppi, Katia
    Usala, Emilio
    Specchia, Giorgina
    Martinelli, Vincenzo
    Palmieri, Fausto
    Pierri, Ivana
    Liberati, Anna Marina
    Iurlo, Alessandra
    Grossi, Alberto
    Vannucchi, Alessandro M.
    Vianelli, Nicola
    Mazzucconi, Maria Gabriella
    LEUKEMIA RESEARCH, 2011, 35 (12) : 1557 - 1563
  • [30] No mutations in the GATA-1 gene detected in patients with acquired essential thrombocythemia
    Gandini, D
    Allen, AJR
    Nash, MJ
    Linch, DC
    Gale, RE
    HAEMATOLOGICA, 2004, 89 (05) : 613 - 615
12345